Abstract
Contracture of phalanges (CP) is a frequent complication of patients with systemic sclerosis (SSc). The objective of this study was to examine the prevalance of CP in patients with SSc and investigate the clinical and laboratory features of SSc patients with CP. Three hundred and fifty patients with SSc were examined. CP was found in 164 of the 350 patients (47%) with SSc. The prevalence of oesophageal involvement, pulmonary fibrosis or heart involvement was significantly greater in the patients with CP than that in those without CP. Our study suggested that the presence of CP may be a marker of oesophageal involvement, pulmonary fibrosis and heart involvement.
Similar content being viewed by others
References
Shero JH, Bordwell B, Rothfield NF, Earnshaw WC (1986) High titers of autoantibodies to topoisomerase I (Scl-70) in sera from scleroderma patients. Science 231:737–740
Ihn H, Yamane K, Yazawa N et al (1999) Distribution and antigen specificity of anti-U1 RNP antibodies in patients with systemic sclerosis. Clin Exp Immunol 117:383–387
Clark JA, Winkelmann R, McDuffie FC, Ward LE (1971) Synovial tissue changes and rheumatoid factor in scleroderma. Mayo Clin Proc 46:97–103
Sato S, Ihn H, Kikuchi K, Takehara K (1994) Antihistone antibobodies in systemic sclerosis. Association with pulmonary fibrosis. Arthritis Rheum 37:391–394
Serup J, Staun-Olsen P (1986) Antinuclear antibodies and anti-DNA antibodies in scleroderma. Allergy 41:452–456
Yamane K, Ihn H, Asano Y, Yazawa N, Kubo M, Kikuchi K, Soma Y, Tamaki K (2000) Clinical and laboratory features of scleroderma patients with pulmonary hypertension. Rheumatology 39:1269–1271
Mimura Y, Ihn H, Jinnin M, Asano Y, Yamane K, Tamaki K (2005) Clinical and laboratory features of scleroderma patients developing skeletal myopathy. Clin Rheumatol 24:99–102
Tamaki T, Mori S, Takehara K (1991) Epidemiological study of patients with systemic sclerosis in Tokyo. Arch Dermatol Res 283:366–371
LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, Rowell N, Wollheim F (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202–205
Steen VD, Powell DL, Medsger TA Jr (1988) Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis. Arthritis Rheum 31:196–203
Ihn H, Sato S, Fujimoto M, Kikuchi K, Igarashi A, Soma Y, Tamaki K, Takehara K (1996) Measurement of anticardiolipin antibodies by ELISA using beta 2-glycoprotein I (beta 2-GPI) in systemic sclerosis. Clin Exp Immunol 105:475–479
Yune HY, Vix VA, Klatte EC (1971) Early fingertip changes in scleroderma. JAMA 215:1113–1116
Wild W, Beetham WP (1975) Erosive arthropathy in systemic scleroderma. JAMA 232:511–512
Steen VD, Ziegler GL, Rodnan GP et al (1984) Clinical and laboratory association of anticentromere antibody in patients with progressive systemic sclerosis. Arthritis Rheum 27:125–131
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ashida, R., Ihn, H., Mimura, Y. et al. Clinical features of scleroderma patients with contracture of phalanges. Clin Rheumatol 26, 1275–1277 (2007). https://doi.org/10.1007/s10067-006-0490-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-006-0490-0